Dabur India Limited (NSE:DABUR)

Market Cap	786.13B -5.7%
Revenue (ttm)	131.93B +5.0%
Net Income	18.95B +7.2%
EPS	10.66 +7.1%
Shares Out	1.77B
PE Ratio	41.57
Forward PE	37.53
Dividend	8.25 (1.89%)
Ex-Dividend Date	Jul 17, 2026

Volume	1,705,313
Open	444.55
Previous Close	443.15
Day's Range	441.05 - 447.00
52-Week Range	403.35 - 577.00
Beta	0.40
Analysts	Buy
Price Target	523.30 (+17.99%)
Earnings Date	Jul 29, 2026

About Dabur India

Dabur India Limited operates as a fast moving consumer goods company worldwide. It operates through Consumer Care Business, Foods Business, Retail Business, and Other segments. The company provides health supplements under the Dabur Chyawanprash, Dabur Honey, and Dabur Glucose brand name; digestive products under the Hajmola and Pudin Hara; cough and cold products under the Honitus brands name; rejuvenators under the Shilajit brand name; health juices; nutraceuticals under the Siens brand name; and baby care products under the Dabur Lal Tail, J...

• Industry: Household & Personal Products
• Sector: Consumer Staples
• Founded: 1884
• Employees: 5,341
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: DABUR

Financial Performance

In fiscal year 2026, Dabur India's revenue was 131.93 billion, an increase of 5.01% compared to the previous year's 125.63 billion. Earnings were 18.95 billion, an increase of 7.21%.

Analyst Summary

According to 37 analysts, the average rating for DABUR stock is "Buy." The 12-month stock price target is ₹523.30, which is an increase of 17.99% from the latest price.

Price Target

₹523.30

(17.99% upside)

Analyst Consensus: Buy

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Jul 10, 2026

Data Sources Report a data error